KPV

• 10mg lyophilized peptide
• Dry-Fill Capsules (various strengths depending on product batch)

• Anti-inflammatory signaling through inhibition of pro-inflammatory cytokines such as TNF-α and IL-6, reducing systemic and localized inflammation markers in studied models.
• Wound healing and tissue repair signals promoting tissue regeneration endpoints and reduced oxidative stress and scarring observations in injury and recovery focused paradigms.
• Antimicrobial activity with broad-spectrum signals against bacteria, fungi, and other pathogens, relevant to immune defense and infection control research designs.

KPV is commonly studied for

• Skin health and inflammatory skin condition endpoints including models relevant to eczema, psoriasis, acne, and related inflammatory presentations
• Gut health and gastrointestinal inflammation paradigms including IBD, ulcerative colitis, and Crohn's disease adjacent research designs
• Tissue repair and wound healing endpoints supporting faster healing and reduced scarring signals in post-surgical recovery and injury repair models

KPV is generally described as well tolerated in research contexts, with minimal adverse observations reported across studied models.

• Topical application contexts are commonly characterized as compatible with most skin type variables, with monitoring advised in sensitive skin adjacent paradigms
• Systemic exposure designs are typically characterized as having a favorable safety profile in the available research literature